Keywords: خط دوم; Mesothelioma; Pleural; Second line; Meta-analysis;
مقالات ISI خط دوم (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: خط دوم; Head & neck cancer; Recurrent; Metastatic; Chemotherapy; Anti-EGFR; Second line;
Keywords: خط دوم; Pancreatic cancer; Second line; Chemotherapy; Oxaliplatin; Irinotecan; Review;
Keywords: خط دوم; EGFR wild type; Multiplex genotyping; Plasma circulating tumor DNA; Randomized phase 2 study; Second line;
Keywords: خط دوم; Angiogenesis inhibitor; Chemotherapy; Combination; Second line; Targeted therapy;
Keywords: خط دوم; Hepatocellular cancer; Target therapies; Second line; Everolimus; Ramucirumab;
Keywords: خط دوم; Angiogenesis; Bevacizumab; Aflibercept; Ramucirumab; Second line; Colorectal cancer;
Keywords: خط دوم; Malignant pleural mesothelioma; Epidemiology; Chemotherapy; Immunotherapy; Second line; Maintenance
Keywords: خط دوم; Mesothelioma; Treatment; Chemotherapy; Second line; Biological; Targeted treatment; Outcome; Meta-analysis;
A review of the mechanism of action and clinical applications of sorafenib in advanced osteosarcoma
Keywords: خط دوم; Sorafenib; Advanced osteosarcoma; Denosumab; Everolimus; Novel therapy; Second line; RANKL; Tyrosine kinase; Nexavar; MTORC; Italian Sarcoma Group; Primary bone cancer; MAPK; ERK; Temsirolimus; Bevacizumab;
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancer
Keywords: خط دوم; Cabazitaxel; Docetaxel; Head and neck cancer; Palliative; Chemotherapy; Second line;
Original ResearchResection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients
Keywords: خط دوم; Colorectal cancer; Liver metastasis; Preoperative chemotherapy; Second line; Hepatectomy;
Cancer bronchique non à petites cellules de stade IV sans addiction oncogénique : traitements en 2e ligne et au-delÃ
Keywords: خط دوم; Cancer bronchique non à petites cellules; Deuxième ligne; Immunothérapie; Anti-angiogénique; Non-small cell lung cancer; Second line; Immunotherapy; Anti-angiogenic drugs;
Afatinib en pacientes con carcinoma escamoso de pulmón: contexto actual y opción de un tratamiento oral
Keywords: خط دوم; Cáncer de pulmón; Cáncer epidermoide; Cáncer avanzado; Segunda línea; Afatinib; ErbB; Erlotinib; QuimioterapiaLung cancer; Epidermoid; Advanced; Second line; Afatinib; ErbB; Erlotinib; Chemotherapy
Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network
Keywords: خط دوم; Sunitinib; Thymic carcinoma; Thymoma; Second line
Is there still a role for sorafenib in metastatic renal cell carcinoma? A systematic review and meta-analysis of the effectiveness of sorafenib over other targeted agents
Keywords: خط دوم; Sorafenib; Sunitinib; Axitinib; Tivozanib; MRCC; Second line; First line; Phase III trial; Phase II trial;
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients
Keywords: خط دوم; ESMO; European Society for Medical Oncology; ASCO; American Society of Clinical Oncology; ECOG; Eastern Cooperative Oncology Group; Non small cell lung cancer; EGFR mutation; EGFR tyrosine kinase inhibitors; First line; Second line; Acquired resistance;
Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study)
Keywords: خط دوم; Non-small cell lung cancer; Chemotherapy; Second line; Cisplatin; Docetaxel; Prognosis;
Maintenance chemotherapy in advanced NSCLC: A population-based assessment of eligibility
Keywords: خط دوم; Maintenance chemotherapy; NSCLC; Performance status; Response; Second line; Population based
Less Toxic Chemotherapy Improves Uptake of All Lines of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A 10-Year Retrospective Population-Based Review
Keywords: خط دوم; Non–small-cell lung cancer; Second line; Predictors; Docetaxel; Pemetrexed; Erlotinib
Rapport du Comité national technique de l’échographie de dépistage prénatal (CNTEDP) : recommandations pour l’échographie de diagnostic
Keywords: خط دوم; Échographie fœtale; Recommandations; Diagnostic; Deuxième intentionPrenatal ultrasound; Recommendations; Second line; Referral
Second line treatment of metastatic renal cell carcinoma: The Institut Gustave Roussy experience with targeted therapies in 251 consecutive patients
Keywords: خط دوم; Targeted therapy; Second line; Metastatic renal cell carcinoma;
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: Multicentre, open-label, phase II safety study
Keywords: خط دوم; Hepatocellular carcinoma; Receptor kinase inhibition; Regorafenib; Safety; Second line; Tolerability;
Efficacy of Pemetrexed as Second-Line Therapy in Advanced NSCLC after Either Treatment-Free Interval or Maintenance Therapy with Gemcitabine or Erlotinib in IFCT-GFPC 05-02 Phase III Study
Keywords: خط دوم; Maintenance; Pemetrexed; Non-Small-Cell Lung Cancer; Second line;
Platinum rechallenge in patients with advanced NSCLC: A pooled analysis
Keywords: خط دوم; NSCLC; Metastatic; Second line; Platinum-based doublets; Rechallenge
Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials
Keywords: خط دوم; Urothelial carcinoma; Second line; Prognosis; Time from prior chemotherapy; Hemoglobin; Liver metastasis; Performance status
Phase II trial of capecitabine combined with thalidomide in second-line treatment of advanced pancreatic cancer
Keywords: خط دوم; Pancreatic cancer; Second line; Capecitabine; Thalidomide;
Phase II study of S-1 monotherapy in platinum-refractory, advanced non-small cell lung cancer
Keywords: خط دوم; Lung cancer; Second line; Platinum-refractory; S-1 monotherapy; Ambulatory setting; Oral medication
Multicenter Phase II Trial of Motexafin Gadolinium and Pemetrexed for Second-Line Treatment in Patients with Non-small Cell Lung Cancer
Keywords: خط دوم; Lung cancer; Motexafin gadolinium; Pemetrexed; Second line
Management of metastatic castration-resistant prostate cancer after first-line docetaxel
Keywords: خط دوم; Castration-resistant prostate cancer; Docetaxel; Second line; Cytotoxic therapy; Hormonal therapy; Immunotherapy; Anti-angiogenic agents; Clusterin-targeted therapy;
Second and third line treatment in non-small cell lung cancer
Keywords: خط دوم; NSCLC; Second line; Docetaxel; Pemetrexed; Targeted therapies
Retreatment with pemetrexed-based chemotherapy in malignant pleural mesothelioma (MPM): A second line treatment option
Keywords: خط دوم; Mesothelioma; Pemetrexed; Second line; Retreatment; Chemotherapy; response
Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis
Keywords: خط دوم; Therapy sequence; Tyrosine kinase inhibitor; Sorafenib; Sunitinib; Renal carcinoma; Second line
A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations
Keywords: خط دوم; HIV-1; Drugs; Second line; Synthesis; Prices; Efavirenz; Tenofovir Disoproxil Fumarate; TDF; Emtricitabine; FTC; Ritonavir; Lopinavir; Kaletra; Atazanavir
A phase II study of days 1 and 8 combination of docetaxel plus gemcitabine for the second-line treatment of patients with advanced non-small-cell lung cancer and good performance status
Keywords: خط دوم; Second line; Docetaxel; Gemcitabine; Non-small-cell lung cancer
Gemcitabine plus oxaliplatin combination (GEMOX regimen) in pretreated patients with advanced non-small cell lung cancer (NSCLC): A multicenter phase II study
Keywords: خط دوم; Oxaliplatin; Gemcitabine; NSCLC; Second line; Phase II
A randomised phase II study of the efficacy and safety of intravenous topotecan in combination with either cisplatin or etoposide in patients with untreated extensive disease small-cell lung cancer
Keywords: خط دوم; Chemotherapy; Second line; Small-cell lung cancer; Topotecan;